0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Self-replicating mRNA Vaccines Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-26F17214
Home | Market Reports | Science| Biological Sciences
Global Self replicating mRNA Vaccines Market Research Report 2024
BUY CHAPTERS

Global Self-replicating mRNA Vaccines Market Research Report 2024

Code: QYRE-Auto-26F17214
Report
June 2024
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Self-replicating mRNA Vaccines Market

A more common name for self-replicating mRNA is self-amplifying RNA (saRNA). The important difference compared to ordinary mRNA is that it can use its own RNA sequence as a template to replicate itself. Usually mRNA encodes the protein that needs to be expressed, and the ribosomes in the cell are used to complete the translation and protein production. In addition to expressing the target protein, saRNA also carries a sequence that can express RNA polymerase (RNA-dependent RNA polymerase, RdRP). After this RNA polymerase is produced, it can use saRNA as a template to produce more copies of saRNA.
The global Self-replicating mRNA Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Self-replicating mRNA Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Self-replicating mRNA Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Self-replicating mRNA Vaccines include Chimeron Bio, Ziphius Vaccines, Aldevron, VaxEquity, Precision Nanosystems, Replicate Bioscience, Elixirgen Therapeutics, Immorna, CSL, Arcturus Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Self-replicating mRNA Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Self-replicating mRNA Vaccines.
The Self-replicating mRNA Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Self-replicating mRNA Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Self-replicating mRNA Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Self-replicating mRNA Vaccines Market Report

Report Metric Details
Report Name Self-replicating mRNA Vaccines Market
Segment by Type
  • Preventive Medicine
  • Medicine
Segment by Application
  • Infectious Disease
  • Cancer
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Chimeron Bio, Ziphius Vaccines, Aldevron, VaxEquity, Precision Nanosystems, Replicate Bioscience, Elixirgen Therapeutics, Immorna, CSL, Arcturus Therapeutics, BioNTech, GSK, Gritstone Bio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Self-replicating mRNA Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Self-replicating mRNA Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Self-replicating mRNA Vaccines Market report?

Ans: The main players in the Self-replicating mRNA Vaccines Market are Chimeron Bio, Ziphius Vaccines, Aldevron, VaxEquity, Precision Nanosystems, Replicate Bioscience, Elixirgen Therapeutics, Immorna, CSL, Arcturus Therapeutics, BioNTech, GSK, Gritstone Bio

What are the Application segmentation covered in the Self-replicating mRNA Vaccines Market report?

Ans: The Applications covered in the Self-replicating mRNA Vaccines Market report are Infectious Disease, Cancer, Others

What are the Type segmentation covered in the Self-replicating mRNA Vaccines Market report?

Ans: The Types covered in the Self-replicating mRNA Vaccines Market report are Preventive Medicine, Medicine

1 Self-replicating mRNA Vaccines Market Overview
1.1 Product Definition
1.2 Self-replicating mRNA Vaccines by Type
1.2.1 Global Self-replicating mRNA Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Preventive Medicine
1.2.3 Medicine
1.3 Self-replicating mRNA Vaccines by Application
1.3.1 Global Self-replicating mRNA Vaccines Market Value by Application (2024-2030)
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Others
1.4 Global Self-replicating mRNA Vaccines Market Size Estimates and Forecasts
1.4.1 Global Self-replicating mRNA Vaccines Revenue 2019-2030
1.4.2 Global Self-replicating mRNA Vaccines Sales 2019-2030
1.4.3 Global Self-replicating mRNA Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Self-replicating mRNA Vaccines Market Competition by Manufacturers
2.1 Global Self-replicating mRNA Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Self-replicating mRNA Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Self-replicating mRNA Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Self-replicating mRNA Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Self-replicating mRNA Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Self-replicating mRNA Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Self-replicating mRNA Vaccines, Date of Enter into This Industry
2.8 Global Self-replicating mRNA Vaccines Market Competitive Situation and Trends
2.8.1 Global Self-replicating mRNA Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Self-replicating mRNA Vaccines Players Market Share by Revenue
2.8.3 Global Self-replicating mRNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Self-replicating mRNA Vaccines Market Scenario by Region
3.1 Global Self-replicating mRNA Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Self-replicating mRNA Vaccines Sales by Region: 2019-2030
3.2.1 Global Self-replicating mRNA Vaccines Sales by Region: 2019-2024
3.2.2 Global Self-replicating mRNA Vaccines Sales by Region: 2025-2030
3.3 Global Self-replicating mRNA Vaccines Revenue by Region: 2019-2030
3.3.1 Global Self-replicating mRNA Vaccines Revenue by Region: 2019-2024
3.3.2 Global Self-replicating mRNA Vaccines Revenue by Region: 2025-2030
3.4 North America Self-replicating mRNA Vaccines Market Facts & Figures by Country
3.4.1 North America Self-replicating mRNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Self-replicating mRNA Vaccines Sales by Country (2019-2030)
3.4.3 North America Self-replicating mRNA Vaccines Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Self-replicating mRNA Vaccines Market Facts & Figures by Country
3.5.1 Europe Self-replicating mRNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Self-replicating mRNA Vaccines Sales by Country (2019-2030)
3.5.3 Europe Self-replicating mRNA Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Self-replicating mRNA Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Self-replicating mRNA Vaccines Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Self-replicating mRNA Vaccines Sales by Region (2019-2030)
3.6.3 Asia Pacific Self-replicating mRNA Vaccines Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Self-replicating mRNA Vaccines Market Facts & Figures by Country
3.7.1 Latin America Self-replicating mRNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Self-replicating mRNA Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Self-replicating mRNA Vaccines Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Self-replicating mRNA Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Self-replicating mRNA Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Self-replicating mRNA Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Self-replicating mRNA Vaccines Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Self-replicating mRNA Vaccines Sales by Type (2019-2030)
4.1.1 Global Self-replicating mRNA Vaccines Sales by Type (2019-2024)
4.1.2 Global Self-replicating mRNA Vaccines Sales by Type (2025-2030)
4.1.3 Global Self-replicating mRNA Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Self-replicating mRNA Vaccines Revenue by Type (2019-2030)
4.2.1 Global Self-replicating mRNA Vaccines Revenue by Type (2019-2024)
4.2.2 Global Self-replicating mRNA Vaccines Revenue by Type (2025-2030)
4.2.3 Global Self-replicating mRNA Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Self-replicating mRNA Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Self-replicating mRNA Vaccines Sales by Application (2019-2030)
5.1.1 Global Self-replicating mRNA Vaccines Sales by Application (2019-2024)
5.1.2 Global Self-replicating mRNA Vaccines Sales by Application (2025-2030)
5.1.3 Global Self-replicating mRNA Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Self-replicating mRNA Vaccines Revenue by Application (2019-2030)
5.2.1 Global Self-replicating mRNA Vaccines Revenue by Application (2019-2024)
5.2.2 Global Self-replicating mRNA Vaccines Revenue by Application (2025-2030)
5.2.3 Global Self-replicating mRNA Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Self-replicating mRNA Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Chimeron Bio
6.1.1 Chimeron Bio Company Information
6.1.2 Chimeron Bio Description and Business Overview
6.1.3 Chimeron Bio Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Chimeron Bio Self-replicating mRNA Vaccines Product Portfolio
6.1.5 Chimeron Bio Recent Developments/Updates
6.2 Ziphius Vaccines
6.2.1 Ziphius Vaccines Company Information
6.2.2 Ziphius Vaccines Description and Business Overview
6.2.3 Ziphius Vaccines Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ziphius Vaccines Self-replicating mRNA Vaccines Product Portfolio
6.2.5 Ziphius Vaccines Recent Developments/Updates
6.3 Aldevron
6.3.1 Aldevron Company Information
6.3.2 Aldevron Description and Business Overview
6.3.3 Aldevron Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Aldevron Self-replicating mRNA Vaccines Product Portfolio
6.3.5 Aldevron Recent Developments/Updates
6.4 VaxEquity
6.4.1 VaxEquity Company Information
6.4.2 VaxEquity Description and Business Overview
6.4.3 VaxEquity Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 VaxEquity Self-replicating mRNA Vaccines Product Portfolio
6.4.5 VaxEquity Recent Developments/Updates
6.5 Precision Nanosystems
6.5.1 Precision Nanosystems Company Information
6.5.2 Precision Nanosystems Description and Business Overview
6.5.3 Precision Nanosystems Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Precision Nanosystems Self-replicating mRNA Vaccines Product Portfolio
6.5.5 Precision Nanosystems Recent Developments/Updates
6.6 Replicate Bioscience
6.6.1 Replicate Bioscience Company Information
6.6.2 Replicate Bioscience Description and Business Overview
6.6.3 Replicate Bioscience Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Replicate Bioscience Self-replicating mRNA Vaccines Product Portfolio
6.6.5 Replicate Bioscience Recent Developments/Updates
6.7 Elixirgen Therapeutics
6.7.1 Elixirgen Therapeutics Company Information
6.7.2 Elixirgen Therapeutics Description and Business Overview
6.7.3 Elixirgen Therapeutics Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Elixirgen Therapeutics Self-replicating mRNA Vaccines Product Portfolio
6.7.5 Elixirgen Therapeutics Recent Developments/Updates
6.8 Immorna
6.8.1 Immorna Company Information
6.8.2 Immorna Description and Business Overview
6.8.3 Immorna Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Immorna Self-replicating mRNA Vaccines Product Portfolio
6.8.5 Immorna Recent Developments/Updates
6.9 CSL
6.9.1 CSL Company Information
6.9.2 CSL Description and Business Overview
6.9.3 CSL Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 CSL Self-replicating mRNA Vaccines Product Portfolio
6.9.5 CSL Recent Developments/Updates
6.10 Arcturus Therapeutics
6.10.1 Arcturus Therapeutics Company Information
6.10.2 Arcturus Therapeutics Description and Business Overview
6.10.3 Arcturus Therapeutics Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Arcturus Therapeutics Self-replicating mRNA Vaccines Product Portfolio
6.10.5 Arcturus Therapeutics Recent Developments/Updates
6.11 BioNTech
6.11.1 BioNTech Company Information
6.11.2 BioNTech Description and Business Overview
6.11.3 BioNTech Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 BioNTech Self-replicating mRNA Vaccines Product Portfolio
6.11.5 BioNTech Recent Developments/Updates
6.12 GSK
6.12.1 GSK Company Information
6.12.2 GSK Description and Business Overview
6.12.3 GSK Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 GSK Self-replicating mRNA Vaccines Product Portfolio
6.12.5 GSK Recent Developments/Updates
6.13 Gritstone Bio
6.13.1 Gritstone Bio Company Information
6.13.2 Gritstone Bio Description and Business Overview
6.13.3 Gritstone Bio Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Gritstone Bio Self-replicating mRNA Vaccines Product Portfolio
6.13.5 Gritstone Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Self-replicating mRNA Vaccines Industry Chain Analysis
7.2 Self-replicating mRNA Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Self-replicating mRNA Vaccines Production Mode & Process
7.4 Self-replicating mRNA Vaccines Sales and Marketing
7.4.1 Self-replicating mRNA Vaccines Sales Channels
7.4.2 Self-replicating mRNA Vaccines Distributors
7.5 Self-replicating mRNA Vaccines Customers
8 Self-replicating mRNA Vaccines Market Dynamics
8.1 Self-replicating mRNA Vaccines Industry Trends
8.2 Self-replicating mRNA Vaccines Market Drivers
8.3 Self-replicating mRNA Vaccines Market Challenges
8.4 Self-replicating mRNA Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Self-replicating mRNA Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Self-replicating mRNA Vaccines Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Self-replicating mRNA Vaccines Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Self-replicating mRNA Vaccines Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Self-replicating mRNA Vaccines Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Self-replicating mRNA Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Self-replicating mRNA Vaccines Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Self-replicating mRNA Vaccines Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Self-replicating mRNA Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Self-replicating mRNA Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Self-replicating mRNA Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Self-replicating mRNA Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Self-replicating mRNA Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Self-replicating mRNA Vaccines as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Self-replicating mRNA Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Self-replicating mRNA Vaccines Sales by Region (2019-2024) & (K Units)
 Table 18. Global Self-replicating mRNA Vaccines Sales Market Share by Region (2019-2024)
 Table 19. Global Self-replicating mRNA Vaccines Sales by Region (2025-2030) & (K Units)
 Table 20. Global Self-replicating mRNA Vaccines Sales Market Share by Region (2025-2030)
 Table 21. Global Self-replicating mRNA Vaccines Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Self-replicating mRNA Vaccines Revenue Market Share by Region (2019-2024)
 Table 23. Global Self-replicating mRNA Vaccines Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Self-replicating mRNA Vaccines Revenue Market Share by Region (2025-2030)
 Table 25. North America Self-replicating mRNA Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Self-replicating mRNA Vaccines Sales by Country (2019-2024) & (K Units)
 Table 27. North America Self-replicating mRNA Vaccines Sales by Country (2025-2030) & (K Units)
 Table 28. North America Self-replicating mRNA Vaccines Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Self-replicating mRNA Vaccines Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Self-replicating mRNA Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Self-replicating mRNA Vaccines Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Self-replicating mRNA Vaccines Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Self-replicating mRNA Vaccines Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Self-replicating mRNA Vaccines Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Self-replicating mRNA Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Self-replicating mRNA Vaccines Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Self-replicating mRNA Vaccines Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Self-replicating mRNA Vaccines Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Self-replicating mRNA Vaccines Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Self-replicating mRNA Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Self-replicating mRNA Vaccines Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Self-replicating mRNA Vaccines Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Self-replicating mRNA Vaccines Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Self-replicating mRNA Vaccines Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Self-replicating mRNA Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Self-replicating mRNA Vaccines Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Self-replicating mRNA Vaccines Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Self-replicating mRNA Vaccines Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Self-replicating mRNA Vaccines Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Self-replicating mRNA Vaccines Sales (K Units) by Type (2019-2024)
 Table 51. Global Self-replicating mRNA Vaccines Sales (K Units) by Type (2025-2030)
 Table 52. Global Self-replicating mRNA Vaccines Sales Market Share by Type (2019-2024)
 Table 53. Global Self-replicating mRNA Vaccines Sales Market Share by Type (2025-2030)
 Table 54. Global Self-replicating mRNA Vaccines Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Self-replicating mRNA Vaccines Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Self-replicating mRNA Vaccines Revenue Market Share by Type (2019-2024)
 Table 57. Global Self-replicating mRNA Vaccines Revenue Market Share by Type (2025-2030)
 Table 58. Global Self-replicating mRNA Vaccines Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Self-replicating mRNA Vaccines Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Self-replicating mRNA Vaccines Sales (K Units) by Application (2019-2024)
 Table 61. Global Self-replicating mRNA Vaccines Sales (K Units) by Application (2025-2030)
 Table 62. Global Self-replicating mRNA Vaccines Sales Market Share by Application (2019-2024)
 Table 63. Global Self-replicating mRNA Vaccines Sales Market Share by Application (2025-2030)
 Table 64. Global Self-replicating mRNA Vaccines Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Self-replicating mRNA Vaccines Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Self-replicating mRNA Vaccines Revenue Market Share by Application (2019-2024)
 Table 67. Global Self-replicating mRNA Vaccines Revenue Market Share by Application (2025-2030)
 Table 68. Global Self-replicating mRNA Vaccines Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Self-replicating mRNA Vaccines Price (US$/Unit) by Application (2025-2030)
 Table 70. Chimeron Bio Company Information
 Table 71. Chimeron Bio Description and Business Overview
 Table 72. Chimeron Bio Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Chimeron Bio Self-replicating mRNA Vaccines Product
 Table 74. Chimeron Bio Recent Developments/Updates
 Table 75. Ziphius Vaccines Company Information
 Table 76. Ziphius Vaccines Description and Business Overview
 Table 77. Ziphius Vaccines Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Ziphius Vaccines Self-replicating mRNA Vaccines Product
 Table 79. Ziphius Vaccines Recent Developments/Updates
 Table 80. Aldevron Company Information
 Table 81. Aldevron Description and Business Overview
 Table 82. Aldevron Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Aldevron Self-replicating mRNA Vaccines Product
 Table 84. Aldevron Recent Developments/Updates
 Table 85. VaxEquity Company Information
 Table 86. VaxEquity Description and Business Overview
 Table 87. VaxEquity Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. VaxEquity Self-replicating mRNA Vaccines Product
 Table 89. VaxEquity Recent Developments/Updates
 Table 90. Precision Nanosystems Company Information
 Table 91. Precision Nanosystems Description and Business Overview
 Table 92. Precision Nanosystems Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Precision Nanosystems Self-replicating mRNA Vaccines Product
 Table 94. Precision Nanosystems Recent Developments/Updates
 Table 95. Replicate Bioscience Company Information
 Table 96. Replicate Bioscience Description and Business Overview
 Table 97. Replicate Bioscience Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Replicate Bioscience Self-replicating mRNA Vaccines Product
 Table 99. Replicate Bioscience Recent Developments/Updates
 Table 100. Elixirgen Therapeutics Company Information
 Table 101. Elixirgen Therapeutics Description and Business Overview
 Table 102. Elixirgen Therapeutics Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Elixirgen Therapeutics Self-replicating mRNA Vaccines Product
 Table 104. Elixirgen Therapeutics Recent Developments/Updates
 Table 105. Immorna Company Information
 Table 106. Immorna Description and Business Overview
 Table 107. Immorna Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Immorna Self-replicating mRNA Vaccines Product
 Table 109. Immorna Recent Developments/Updates
 Table 110. CSL Company Information
 Table 111. CSL Description and Business Overview
 Table 112. CSL Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. CSL Self-replicating mRNA Vaccines Product
 Table 114. CSL Recent Developments/Updates
 Table 115. Arcturus Therapeutics Company Information
 Table 116. Arcturus Therapeutics Description and Business Overview
 Table 117. Arcturus Therapeutics Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Arcturus Therapeutics Self-replicating mRNA Vaccines Product
 Table 119. Arcturus Therapeutics Recent Developments/Updates
 Table 120. BioNTech Company Information
 Table 121. BioNTech Description and Business Overview
 Table 122. BioNTech Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. BioNTech Self-replicating mRNA Vaccines Product
 Table 124. BioNTech Recent Developments/Updates
 Table 125. GSK Company Information
 Table 126. GSK Description and Business Overview
 Table 127. GSK Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. GSK Self-replicating mRNA Vaccines Product
 Table 129. GSK Recent Developments/Updates
 Table 130. Gritstone Bio Company Information
 Table 131. Gritstone Bio Description and Business Overview
 Table 132. Gritstone Bio Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Gritstone Bio Self-replicating mRNA Vaccines Product
 Table 134. Gritstone Bio Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Self-replicating mRNA Vaccines Distributors List
 Table 138. Self-replicating mRNA Vaccines Customers List
 Table 139. Self-replicating mRNA Vaccines Market Trends
 Table 140. Self-replicating mRNA Vaccines Market Drivers
 Table 141. Self-replicating mRNA Vaccines Market Challenges
 Table 142. Self-replicating mRNA Vaccines Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Self-replicating mRNA Vaccines
 Figure 2. Global Self-replicating mRNA Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Self-replicating mRNA Vaccines Market Share by Type: 2023 & 2030
 Figure 4. Preventive Medicine Product Picture
 Figure 5. Medicine Product Picture
 Figure 6. Global Self-replicating mRNA Vaccines Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Self-replicating mRNA Vaccines Market Share by Application: 2023 & 2030
 Figure 8. Infectious Disease
 Figure 9. Cancer
 Figure 10. Others
 Figure 11. Global Self-replicating mRNA Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Self-replicating mRNA Vaccines Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Self-replicating mRNA Vaccines Sales (2019-2030) & (K Units)
 Figure 14. Global Self-replicating mRNA Vaccines Average Price (US$/Unit) & (2019-2030)
 Figure 15. Self-replicating mRNA Vaccines Report Years Considered
 Figure 16. Self-replicating mRNA Vaccines Sales Share by Manufacturers in 2023
 Figure 17. Global Self-replicating mRNA Vaccines Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Self-replicating mRNA Vaccines Players: Market Share by Revenue in Self-replicating mRNA Vaccines in 2023
 Figure 19. Self-replicating mRNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Self-replicating mRNA Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Self-replicating mRNA Vaccines Sales Market Share by Country (2019-2030)
 Figure 22. North America Self-replicating mRNA Vaccines Revenue Market Share by Country (2019-2030)
 Figure 23. United States Self-replicating mRNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Self-replicating mRNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Self-replicating mRNA Vaccines Sales Market Share by Country (2019-2030)
 Figure 26. Europe Self-replicating mRNA Vaccines Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Self-replicating mRNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Self-replicating mRNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Self-replicating mRNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Self-replicating mRNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Self-replicating mRNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Self-replicating mRNA Vaccines Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Self-replicating mRNA Vaccines Revenue Market Share by Region (2019-2030)
 Figure 34. China Self-replicating mRNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Self-replicating mRNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Self-replicating mRNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Self-replicating mRNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Self-replicating mRNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Self-replicating mRNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Self-replicating mRNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Self-replicating mRNA Vaccines Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Self-replicating mRNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Self-replicating mRNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Self-replicating mRNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Self-replicating mRNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Self-replicating mRNA Vaccines Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Self-replicating mRNA Vaccines Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Self-replicating mRNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Self-replicating mRNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Self-replicating mRNA Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Self-replicating mRNA Vaccines by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Self-replicating mRNA Vaccines by Type (2019-2030)
 Figure 53. Global Self-replicating mRNA Vaccines Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Self-replicating mRNA Vaccines by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Self-replicating mRNA Vaccines by Application (2019-2030)
 Figure 56. Global Self-replicating mRNA Vaccines Price (US$/Unit) by Application (2019-2030)
 Figure 57. Self-replicating mRNA Vaccines Value Chain
 Figure 58. Self-replicating mRNA Vaccines Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6C20013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K19803
Thu Sep 11 00:00:00 UTC 2025

Add to Cart